Newsroom | 5028 results

FT. LAUDERDALE, Fla.--(BUSINESS WIRE)--Trividia Health, Inc., announced today that it is initiating a labeling correction which requires a modification of the Owner’s Booklets/System Instructions for Use for all TRUE METRIX, TRUE METRIX AIR, TRUE METRIX GO, and TRUE METRIX PRO Blood Glucose Monitoring Systems (collectively, the “Products”) distributed in the United States, United Kingdom, Mexico, Australia, and the Caribbean. Trividia is updating the E-5 Error Code in the “Messages” section of...

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2026 first quarter ended December 31, 2025. The Company is hosting a conference call today, February 5, 2026, at 4:30 p.m. ET to discuss the results. “We had another quarter of strong execution across all areas of our business and we think Arrowhead is extremely well positioned to build on this progress throughout 2026 and beyond,” said Christopher Anzalone, Ph.D.,...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care...

SAN DIEGO--(BUSINESS WIRE)--Dexcom, Inc. (Nasdaq:DXCM), the global leader in glucose biosensing, announced it will roll out an advanced AI-enabled enhancement to Stelo that will transform how users understand their glucose health and take steps in achieving their long-term health goals. The newest features will launch nationwide in the coming weeks. Last year, Dexcom introduced AI-driven Smart Food Logging in Stelo, the first over-the-counter glucose biosensor cleared1 by the FDA in the United...

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its fourth quarter and full year 2025 financial results before the opening of the financial markets on Tuesday, February 24, 2026. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities...

PALO ALTO, Calif.--(BUSINESS WIRE)--Glooko, Inc. a global leader in connected care and glycemic management solutions, today announced the appointment of Mark Laret, one of the nation’s leading healthcare operators and strategists, to its Board of Directors. “As healthcare moves toward a more connected, data-driven future, health systems need partners who understand both the complexities of inpatient workflows and the realities of outpatient glycemic management,” said Mike Alvarez, Chief Executi...

DUBLIN--(BUSINESS WIRE)--The "GLP-1 Analogues Market" report has been added to ResearchAndMarkets.com's offering. This report provides detailed information on glucagon-like peptide-1 (GLP-1) analogues. It analyzes market trends for GLP-1 analogues, with data from 2024, estimates from 2025, projections of compound annual growth rates (CAGRs) through 2030 (the forecast period 2025-2030) and regional markets for GLP-1 analogues. This report highlights the current and future market potential of GLP...

LONDON--(BUSINESS WIRE)--Automata, the lab automation company building fully integrated, AI-ready platforms for life sciences, today announced the close of a $45 million Series C funding round led by Dimension with participation from Danaher Ventures, Tru Arrow Partners, Octopus Ventures, Entrepreneurs First, and others. The round also includes a strategic investment partnership with Danaher Corporation, with Murali Venkatesan Ph.D., Global Head of Danaher Ventures and Vice President of Science...

ROCK HILL, S.C.--(BUSINESS WIRE)--Vynleads launches DWX Lifestyle Blueprint™ Technology Platform, an AI-powered health coach transforming wellness into structured routines....

AUSTIN, Texas--(BUSINESS WIRE)--Texicare, the health affiliate of Texas Mutual, is partnering with Virta Health, the leader in reversing metabolic disease, to expand care options for Texas small business employees. Through the collaboration, Texicare members gain access to Virta's virtual clinic programs for Type 2 diabetes reversal at no additional cost. One in eight Texas adults has been diagnosed with diabetes—part of a nationwide epidemic affecting over 38 million Americans. Clinical resear...